Compounds > ampelopsin
Page last updated: 2024-09-04

ampelopsin and Colorectal Neoplasms

ampelopsin has been researched along with Colorectal Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Azami, NLB; Fang, Z; Feng, Y; Li, Q; Sun, M; Sun, X; Wang, Y; Wang, Z; Zhang, L1
Chen, MT; Kang, C; Liu, K; Mi, MT; Wang, B; Wang, XL; Zhang, QY; Zhang, Y; Zhou, M; Zhu, JD; Zhu, XH1
Chen, J; E, Q; Feng, Y; Ji, Q; Li, Q; Liu, X; Sui, H; Sun, X; Wang, Z; Wu, L; Zhou, L1

Other Studies

3 other study(ies) available for ampelopsin and Colorectal Neoplasms

ArticleYear
Dihydromyricetin reverses MRP2-induced multidrug resistance by preventing NF-κB-Nrf2 signaling in colorectal cancer cell.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2021, Volume: 82

    Topics: Animals; Apoptosis; Colonic Neoplasms; Colorectal Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flavonols; HCT116 Cells; Humans; Male; Mice; Mice, Inbred BALB C; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; NF-E2-Related Factor 2; NF-kappa B; Oxaliplatin; Signal Transduction; Vincristine

2021
Dietary Factors Modulate Colonic Tumorigenesis Through the Interaction of Gut Microbiota and Host Chloride Channels.
    Molecular nutrition & food research, 2018, Volume: 62, Issue:5

    Topics: Animals; Bacterial Adhesion; Bile Acids and Salts; Butyrates; Chloride Channels; Colorectal Neoplasms; Cystic Fibrosis Transmembrane Conductance Regulator; Diet; Flavonols; Gastrointestinal Microbiome; Male; Mice; Mice, Inbred BALB C

2018
Dihydromyricetin reverses MRP2-mediated MDR and enhances anticancer activity induced by oxaliplatin in colorectal cancer cells.
    Anti-cancer drugs, 2017, Volume: 28, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Colorectal Neoplasms; Down-Regulation; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Flavonols; HCT116 Cells; Humans; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; NF-E2-Related Factor 2; Organoplatinum Compounds; Oxaliplatin; Promoter Regions, Genetic

2017